Mitral regurgitation in patients with hypertrophic cardiomyopathy: a case series
Mitral regurgitation is linked to adverse cardiac outcomes, often contributing towards symptoms, poor functional capacity, hospitalization, and advanced therapies. Complex and interlinked biomechanical factors lead to MR, often co-existing with LVOT obstruction. Multimodality imaging with echocardiography (transthoracic and transoesophageal) and cardiac magnetic resonance imaging plays a key role in determining the aetiology of MR in HCM. This case series highlights the role of this comprehensive assessment, paving the way for a personalized treatment pathway for patients.
Authors
- Tiziana Felice (ORCID: https://orcid.org/0000-0002-8220-5848)
- Mark Abela (ORCID: https://orcid.org/0000-0003-1050-1637)
- Andrea Calleja
- Kentaro Yamagata (ORCID: https://orcid.org/0000-0003-4124-6421)
Institutions
- Manchester Metropolitan University (GB)
- St George's, University of London (GB)
- University of Malta (MT)
- Mater Dei Hospital (MT)
- Genomics England (GB)
- Genomics (United Kingdom) (GB)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1093/ehjcr/ytaf113
- Citations
- 2
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.78